An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population

Psychiatry and Clinical Neurosciences

Volumn 51, Issue 5, 1997, Pages 333-335

  Ishiguro, Hiroki ^a,b   Arinami, Tadao ^b   Yamada, Kazuo ^a   Otsuka, Yukino ^b   Toru, Michio ^a   Shibuya, Haruo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Agoraphobia; Association; Panic disorder; Polymorphism; Promoter; Serotonin transporter gene

Indexed keywords

DNA; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 17Q; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC TRANSCRIPTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PANIC; SEROTONIN UPTAKE;

EID: 0030732763     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1997.tb03208.x     Document Type: Article

References (18)

1. Murray R, Reveley A. The genetic contribution to neuroses. Br. J. Hosp. Med. 1981; 25: 185-190.
2. Pauls D, Bucher K, Crowe R, Noyes R. A genetic study of panic-disorder pedigrees. Am. J. Hum. Genet. 1980; 32: 639-644.
3. Vieland V, Hodge S, Lish J, Adams P, Weissman M. Segregation analysis of panic disorder. Psychiatric Genet. 1993; 3: 63-71.
4. Kato T, Wang ZW, Zoega T, Crowe RR. Missense mutation of the cholecystokinin B receptor gene: Lack of association with panic disorder. Am. J. Med. Genet. 1996; 67: 401-405.
5. Crawford F, Hoyne J, Diaz P et al. Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder. Am. J. Med. Genet. 1995; 60: 332-334.
6. McGeer PL, McGeer EG. Chemistry of mood and emotion. Ann. Rev. Psychol. 1980; 31: 273-307.
7. Donald F, Klein DF. Panic disorder and agoraphobia: Hypothesis hothouse. J. Clin. Psychiatry 1996; 57: 21-27.
8. Graff FG, Silveira MC, Nogueira RL, Audi EA, Oliveira RM. Neuroanatomy and neurotransmitter regulation of defensive behav- iors and related emotions in mammals. Braz. J. Med. Biol. Res. 1994; 27: 811-829.
9. Schneider P, Evans L, Ross-Lee L et al. Plasma biogenic amine levels in agoraphobia with panic attacks. Pharmacopsychiatry 1987; 20: 102-104.
10. Flaskos J, Theophilopoulos N, George AJ. Platelet monoamine oxidase activity and 5-hydroxytryptamine uptake in agoraphobic patients. Br. J. Psychiatry 1989; 155: 680-685.
11. Sheehan DV, Davidson J, Manschreck T, Van Wyck Fleet J. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J. Clin. Psychapharmacol. 1983; 3: 28-31.
12. Heils A, Teufel A, Petri T et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996; 6: 2612-2624.
13. Losch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
14. Di Bella D, Catalano M, Balling U, Smeraldi E, Lesch KP. Systemic screening for mutations in the coding region of the huma serotonin transporter (5-HTT) gene using PCR and DGGE. Am. J. Med. Genet. 1996; 67: 541-545.
15. Ogilrie AD, Battersby S, Bubb VJ et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996; 347: 731-733.
16. Charney DS, Krystal JH, Southwick SM. Serotonin function in panic and generalized anxiety disorders. Psychiatric Annals. 1990; 20: 593-602.
17. Parent A, Descarries L, Beaudet A. Organization of ascending serotonergic systems in the adult rat brain: A radioautographic study after intraventricular administration of [3H]5-hydroxytryptamine. Neurosceince 1981; 6: 115-138.
18. Steinbusch HWM. Distribution of serotonin immunoreactivity in the central nervous system of the rat: Cell bodies and terminals Neuroscience 1981; 6: 557-618.